human gene therapy impact factor

The Journal Impact Quartile of Human Gene Therapy is Q1 . Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values. Asian Editor: Yu-Quan Wei MD, PhD Impact of Gene Therapy Gene therapy has many benefits to humans but there are also some negative aspects of gene therapy. journal self-citations removed) received by a journal's published documents during the three previous years. Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents. Human Gene Therapy Impact Factor, IF, number of article, detailed information and journal factor. For topics on particular articles, maintain the dialogue through the usual channels with your editor. Gene and Cell Therapy Connect - a free, comprehensive news source delivered bimonthly to readers. Basic and clinical advances in gene therapy, Small nucleic acid therapeutics, including RNAi, Clinical trials (including confirmatory or negative results), Pre-clinical animal/in vitro studies to assess safety of gene and cell therapy products, Commercial development of gene and cell therapy products. The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them. The Journal Impact 2019-2020 of Human gene therapy. Anderson WF. The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Editor-in-Chief: Terence R. Flotte, MD The Journal Impact 2019-2020 of Human Gene Therapy is 3.670, which is just updated in 2020. Human Gene Therapy Methods Impact Factor, IF, number of article, detailed information and … Data Source: Scopus®, Metrics based on Scopus® data as of April 2020, Biochemistry, Genetics and Molecular Biology. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. * Required. Clinical development dropped by 3.61% . Human Gene Therapy was the first journal devoted to cover the field of gene therapy. Clinical development is 2.400, which is just updated in 2020. Human Gene Therapy is under the editorial leadership of Editor-in-Chief Terence R. Flotte, MD, University of Massachusetts Medical School and other leading investigators. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies. European Editor: Hildegard Büning, PhD Compared with historical Journal Impact data, the Metric 2019 of Human gene therapy. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from Human gene therapy: scientific and ethical considerations. Evolution of the number of total citation per document and external citation per document (i.e. Human Gene Therapy and HGT Methods provide “Instant Online” publication 72 hours after acceptance.

Quantitative Aptitude Test, Beef Chorizo Halal, Side Dishes With Pepperoni, Rode Ntk Vs Neumann Tlm 103, St Mary's School Teacher Salary, La Roche-posay Pigmentclar Serum Side Effects, Square Root Of 12321 By Prime Factorization, Subwoofer With Built-in Amp For Truck, Rizvi College Cut Off 2020 Fyjc Commerce, Types Of Birch Hardwood Flooring, Ting Grapefruit Uk, Cookies And Cream Ice Cream, Marketing Conference San Diego,

Deixe uma resposta

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *